Loading...
XAMS
VALUE
Market cap62mUSD
Jul 10, Last price  
6.80EUR
1D
2.26%
1Q
3.82%
Jan 2017
14.09%
IPO
693.34%
Name

Value8 NV

Chart & Performance

D1W1MN
XAMS:VALUE chart
P/E
3.31
P/S
19.48
EPS
2.05
Div Yield, %
3.01%
Shrs. gr., 5y
-0.26%
Rev. gr., 5y
30.88%
Revenues
3m
-46.70%
6,500,0007,910,000000111,732,00098,521,000107,630,000103,944,000141,181,000174,848,00024,145,0006,607,0006,207,000747,0004,164,0004,153,0003,285,0005,383,0002,869,000
Net income
17m
+136.48%
1,465,000723,0003,842,000354,0002,929,0001,933,0002,277,0001,104,0004,554,0005,216,000-1,665,00021,111,0004,318,0004,500,0008,751,00018,428,000-2,531,0005,820,0007,136,00016,875,000
CFO
-904k
L
997,000429,000513,000-201,000-81,000-1,604,000680,0005,247,000-514,0003,317,0001,061,0004,752,00034,295,000186,000-2,393,0001,788,000-385,000-1,286,0006,369,000-904,000
Dividend
Jul 07, 20250.2 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Operating as a private equity entity, Value8 N.V. focuses on providing growth capital to small and medium-sized enterprises. Its investment portfolio spans a broad range of industries, including food, healthcare, business and financial services, energy, security, environmental services, leisure, luxury goods, and internet-based ventures. Geographically, the firm's focus is primarily on Western Europe, with a strong emphasis on the Netherlands, Belgium, and France. Value8 targets companies with an enterprise valuation ranging from €5 million (approximately $6.96 million) up to €150 million (around $208.87 million). It actively seeks board representation in its portfolio companies and typically aims for a public offering as its exit strategy. Established in 2008, Value8 N.V. maintains its headquarters in Bussum, the Netherlands.
IPO date
Sep 24, 2008
Employees
908
Domiciled in
NL
Incorporated in
NL

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT